ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis

BACKGROUND: Non-alcoholic Fatty Liver Disease (NAFLD), now better known as Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and its progression to Nonalcoholic Steatohepatitis (NASH), more recently referred to as Metabolic (Dysfunction)-Associated Steatohepatitis (MASH) are the most co...

Descripción completa

Detalles Bibliográficos
Autores principales: Convertini, Paolo, Santarsiero, Anna, Todisco, Simona, Gilio, Michele, Palazzo, Donatella, Pappalardo, Ilaria, Iacobazzi, Dominga, Frontuto, Maria, Infantino, Vittoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463545/
https://www.ncbi.nlm.nih.gov/pubmed/37620891
http://dx.doi.org/10.1186/s12967-023-04431-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463545/
https://www.ncbi.nlm.nih.gov/pubmed/37620891
http://dx.doi.org/10.1186/s12967-023-04431-w

Ejemplares similares